Potential offlabel or alternative uses discussed in medical settings can include appetite control during weight regain risk periods, or metabolic support in people with insulin resistance, but these uses depend on local regulations and individual medical assessment
Lohscheider JN, Rojas-Sttz MC, Rothbart M, Andersson U, Funck D, Mendgen K, Grimm B, Adamska I (2015) Altered levels of LIL3 isoforms in Arabidopsis lead to disturbed pigment-protein assembly and chlorophyll synthesis, chlorotic phenotype and impaired photosynthetic performance
They stated that: "It is important for veterinarians to have an understanding of how much a biomarker value could change over time due to randomness vs
Medicaid covers GLP-1 weight loss injections like Wegovy, Ozempic, and Zepbound in some states but not others